Brian S Muehl, Age 58530 Leisure Ln, Greenwood, IN 46142

Brian Muehl Phones & Addresses

530 Leisure Ln, Greenwood, IN 46142 (317) 882-9508

940 Country Jct, Indianapolis, IN 46217 (317) 882-9508

Muncie, IN

Lafayette, IN

530 Leisure Ln, Greenwood, IN 46142

Work

Company: Vesta pharmaceuticals - Indianapolis, IN Mar 2011 Position: Quality manager

Education

School / High School: Ball State University- Muncie, IN May 1992 Specialities: Master of Science in Chemistry

Mentions for Brian S Muehl

Resumes & CV records

Resumes

Brian Muehl Photo 11

Quality Systems Supervisor

Location:
1255 Lynnfield Rd, Memphis, TN 38119
Industry:
Staffing And Recruiting
Work:
Medtornic Plainfield
Quality Systems Supervisor
Aerotek
Quality Assurance Scientist at Aerotek
Skills:
Quality Assurance, Recruiting
Brian Muehl Photo 12

Brian Muehl

Brian Muehl Photo 13

Brian Muehl - Greenwood, IN

Work:
VESTA PHARMACEUTICALS - Indianapolis, IN Mar 2011 to Nov 2013
Quality Manager
POLYMER TECHNOLOGY SYSTEMS, INC - Indianapolis, IN 2010 to 2011
Project Leader
BAXTER PHARMA - Bloomington, IN 2009 to 2010
Quality Assurance Line Operator
ROCHE DIAGNOSTICS - Indianapolis, IN 2006 to 2008
Process Validation Scientist
ELI LILLY AND CO - Indianapolis, IN 1992 to 2006
Synthetic Medicinal Chemist
BALL STATE UNIVERSITY - Muncie, IN 1990 to 1992
Synthetic Organic Chemist
Education:
Ball State University - Muncie, IN May 1992
Master of Science in Chemistry
Purdue University - W Lafayette, IN May 1988
Bachelor of Science in Chemistry/Chemistry Ed

Publications & IP owners

Wikipedia

Brian Muehl Photo 15

Brian Muehl

Brian Muehl born in the 1950s, is an American book writer, and a former Sesame Street puppeteer living in Connecticut. Brian's muppet characters included Telly Monster, Barkley the dog ...

Us Patents

-Substituted-1-Benzyl-Napthyls

US Patent:
6384053, May 7, 2002
Filed:
Mar 10, 1995
Appl. No.:
08/402089
Inventors:
Brian S. Muehl - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514319, 514212, 5142392, 514428, 514651, 540596, 540612, 544153, 544398, 546205, 546300, 546302, 548565, 564323, 564324
Abstract:
This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 1-benzyl-naphthyls which are -substituted with ether, thioether amino, cyano or halo that are useful for the treatment of the various medical indications associated with post-menopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus and cervix. The present invention further relates to intermediate compounds and processes useful for preparing the pharmaceutically active compounds of the present invention, and pharmaceutical compositions.

Hexamethyleneiminyl Tachykinin Receptor Antagonists

US Patent:
6403577, Jun 11, 2002
Filed:
Nov 17, 1993
Appl. No.:
08/153847
Inventors:
Sung Y. Cho - Indianapolis IN
Thomas A. Crowell - Indianapolis IN
Bruce D. Gitter - Carmel IN
Philip A. Hipskind - New Palestine IN
J. Jeffry Howbert - Bellevue WA
Karen L. Lobb - Indianapolis IN
Brian S. Muehl - Indianapolis IN
James A. Nixon - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
51421708, 5142352, 51425409, 514307, 514314, 514323, 514339, 514414, 514415, 514438, 540602, 544143, 544373, 546146, 546175, 546201, 5462774, 548455, 548491, 548506
Abstract:
This invention provides a novel series of non-peptidyl compounds which are useful in the treatment or prevention of a physiological disorder associated with an excess of tachykinins. This invention also provides methods for the treatment of such physiological disorders as well as pharmaceutical formulations which employ these novel compounds.

Naphthyl Compounds, Intermediates, Processes, Compositions, And Methods

US Patent:
6410564, Jun 25, 2002
Filed:
Apr 21, 1995
Appl. No.:
08/428922
Inventors:
Henry U. Bryant - Indianapolis IN
George J. Cullinan - Trafalgar IN
Jeffrey A. Dodge - Indianapolis IN
Kennan J. Fahey - Indianapolis IN
Charles D. Jones - Indianapolis IN
Charles W. Lugar - McCordsville IN
Brian S. Muehl - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514319, 514212, 514428, 514650, 540609, 546195, 546205, 548528, 548576
Abstract:
The present invention provides a compound of formula I wherein R is âH, âOH, âO(C -C alkyl) , âOCOC H , âOCO(C -C alkyl), or âOSO (C -C alkyl); R is âH, âOH, âO(C -C alkyl), âOCOC H , âOCO(C -C alkyl) or âOSO (C -C alkyl); n is 2 or 3; and R is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Compounds of formula I are useful in treating osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer.

Selective 3 Adrenergic Agonists

US Patent:
6413991, Jul 2, 2002
Filed:
Jun 30, 2000
Appl. No.:
09/610096
Inventors:
Thomas A. Crowell - Indianapolis IN
Deborah A. Evrard - Indianapolis IN
Charles D. Jones - Indianapolis IN
Brian S. Muehl - Indianapolis IN
Christopher J. Rito - Mooresville IN
Anthony J. Shuker - Indianapolis IN
Andrew J. Thorpe - Ann Arbor MI
Kenneth J. Thrasher - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 314439
US Classification:
514339, 514411, 5462767, 548444
Abstract:
Disclosed herein are selective beta 3 adrenergic agonists represented by the following structural formula: The variables in the structural formula shown above are defined in the specification. Also disclosed are methods of using these compounds for agonizing the beta 3 adrenergic receptor in patients in need of such treatment, for example, patients in need of treatment for obesity or Type II diabetes.

3-Benzyl-Benzothiophenes

US Patent:
6417199, Jul 9, 2002
Filed:
Sep 29, 1995
Appl. No.:
08/536902
Inventors:
Brian S. Muehl - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514324, 514212, 5142388, 514422, 514443, 540596, 544146, 546202, 548525, 548527
Abstract:
This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 3-benzyl-benzothiophenes which are a-substituted with ether, thioether amino, hydrazino, cyano or halo that are useful for the treatment of the various medical indications associated with post-menopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus and cervix. The present invention further relates to intermediate compounds and processes useful for preparing the pharmaceutically active compounds of the present invention, and pharmaceutical compositions.

Naphthyl Compounds, Intermediates, Processes, Compositions, And Methods

US Patent:
6437137, Aug 20, 2002
Filed:
Apr 21, 1995
Appl. No.:
08/426318
Inventors:
Henry U. Bryant - Indianapolis IN
George J. Cullinan - Trafalgar IN
Jeffrey A. Dodge - Indianapolis IN
Kennan J. Fahey - Indianapolis IN
Charles D. Jones - Indianapolis IN
Charles W. Lugar - McCordsville IN
Brian S. Muehl - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D21106
US Classification:
546205, 540609, 548565, 564352
Abstract:
The invention is a process for preparing a compound of formula Ia comprising reducing the compound of formula IIId wherein R is 1-piperidinyl, 1-pyrrolidinyl, dimethylamino, diethylamino or 1-hexamethyleneimino, R , R , R , R , and n are as defined in the specification, with a reducing agent in the presence of a solvent, heating to reflux.

Alpha-Substituted-1-Benzyl-Napthyls

US Patent:
6451817, Sep 17, 2002
Filed:
Sep 29, 1995
Appl. No.:
08/536337
Inventors:
Brian S. Muehl - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A01N 4340
US Classification:
514319, 514212, 5142392, 514428, 514651, 540596, 540612, 544153, 544398, 546205, 546300, 546302, 548565, 564323, 564324
Abstract:
This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 1-benzyl-naphthyls which are -substituted with ether, thioether, amino, hydrazino, cyano or halo that are useful for the treatment of the various medical indications associated with post-menopausal syndrome, as well as estrogen dependent diseases including cancer of the breast, uterus and cervix. The present invention further relates to intermediate compounds and processes useful for preparing the pharmaceutically active compounds of the present invention, and pharmaceutical compositions.

Growth Hormone Secretagogues

US Patent:
6639076, Oct 28, 2003
Filed:
Apr 17, 2001
Appl. No.:
09/762529
Inventors:
Kenneth Lee Hauser - Greencastle IN
Jeffrey Alan Dodge - Indianapolis IN
Mark Louis Heiman - Indianapolis IN
Scott Alan Jones - Indianapolis IN
Charles Arthur Alt - Greenwood IN
Henry Uhlman Bryant - Indianapolis IN
James Densmore Copp - Greenwood IN
William Harlan Gritton - Zionsville IN
Brian Stephen Muehl - Indianapolis IN
Alan David Palkowitz - Carmel IN
Andrew Michael Ratz - Greenwood IN
Gary Anthony Rhodes - Indianapolis IN
Roger Lewis Robey - Greenwood IN
Timothy Alan Shepherd - Indianapolis IN
Kenneth Jeff Thrasher - Indianapolis IN
William George Trankle - Southport IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D40112
US Classification:
546210, 514 16, 514 18, 514 19, 514222, 5142312, 514249, 514255, 514315, 514396, 514397, 530331, 546207, 546208, 546209, 546212, 5483001, 5483111, 5483147, 5483151, 5483157
Abstract:
This invention relates to novel compounds of formula I wherein A, B, D, E, G, J, L, X, V are as defined in the specification, and the compounds are useful in the modulation of endogenous growth hormone levels in a mammal.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.